Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Bladder Neoplasms | 40 | 2024 | 2195 | 3.710 |
Why?
|
Cystectomy | 24 | 2024 | 603 | 3.230 |
Why?
|
Prostatic Neoplasms | 40 | 2024 | 11101 | 2.320 |
Why?
|
Prostate-Specific Antigen | 12 | 2024 | 2463 | 1.450 |
Why?
|
BCG Vaccine | 5 | 2024 | 381 | 1.150 |
Why?
|
Prostatectomy | 13 | 2024 | 1786 | 1.060 |
Why?
|
Testicular Neoplasms | 7 | 2023 | 806 | 0.860 |
Why?
|
Carcinoma, Transitional Cell | 6 | 2022 | 794 | 0.780 |
Why?
|
Androgen Antagonists | 5 | 2024 | 1412 | 0.750 |
Why?
|
Kallikreins | 2 | 2018 | 219 | 0.690 |
Why?
|
Muscle Neoplasms | 2 | 2019 | 130 | 0.670 |
Why?
|
Carcinoma, Renal Cell | 8 | 2023 | 3187 | 0.650 |
Why?
|
Neoplasm Invasiveness | 16 | 2024 | 3618 | 0.650 |
Why?
|
Metformin | 3 | 2017 | 909 | 0.610 |
Why?
|
5-alpha Reductase Inhibitors | 2 | 2022 | 112 | 0.600 |
Why?
|
Kidney Neoplasms | 8 | 2023 | 4282 | 0.580 |
Why?
|
Watchful Waiting | 4 | 2019 | 492 | 0.530 |
Why?
|
Urinary Diversion | 1 | 2016 | 134 | 0.510 |
Why?
|
Neoadjuvant Therapy | 8 | 2024 | 2902 | 0.480 |
Why?
|
Laparoscopy | 6 | 2023 | 2042 | 0.460 |
Why?
|
Bacterial Toxins | 2 | 2019 | 922 | 0.450 |
Why?
|
Prostatic Hyperplasia | 2 | 2015 | 516 | 0.440 |
Why?
|
Postoperative Complications | 15 | 2023 | 15831 | 0.430 |
Why?
|
Aftercare | 2 | 2018 | 916 | 0.420 |
Why?
|
Male | 95 | 2024 | 364641 | 0.380 |
Why?
|
Hypoglycemic Agents | 2 | 2014 | 3108 | 0.380 |
Why?
|
Neoplasm Recurrence, Local | 9 | 2024 | 9412 | 0.370 |
Why?
|
Urologic Neoplasms | 3 | 2019 | 314 | 0.350 |
Why?
|
Neoplasm Staging | 19 | 2024 | 11221 | 0.350 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 3 | 2023 | 498 | 0.340 |
Why?
|
Prostate | 8 | 2023 | 1765 | 0.340 |
Why?
|
Aged | 59 | 2024 | 171446 | 0.340 |
Why?
|
Genetic Engineering | 1 | 2015 | 935 | 0.330 |
Why?
|
Humans | 115 | 2024 | 767991 | 0.310 |
Why?
|
Disease Management | 2 | 2017 | 2533 | 0.300 |
Why?
|
Varicocele | 1 | 2008 | 75 | 0.290 |
Why?
|
Physicians, Primary Care | 2 | 2024 | 624 | 0.280 |
Why?
|
Bacterial Proteins | 2 | 2019 | 3841 | 0.260 |
Why?
|
Venous Thromboembolism | 2 | 2018 | 1883 | 0.260 |
Why?
|
Germ-Line Mutation | 3 | 2024 | 1883 | 0.260 |
Why?
|
Urothelium | 2 | 2018 | 275 | 0.260 |
Why?
|
Middle Aged | 53 | 2024 | 223422 | 0.250 |
Why?
|
Diagnostic Imaging | 3 | 2015 | 3532 | 0.240 |
Why?
|
Antibiotic Prophylaxis | 2 | 2023 | 640 | 0.240 |
Why?
|
Prospective Studies | 19 | 2024 | 54924 | 0.240 |
Why?
|
Chemotherapy, Adjuvant | 6 | 2018 | 3553 | 0.240 |
Why?
|
Incidence | 11 | 2023 | 21532 | 0.240 |
Why?
|
Retrospective Studies | 30 | 2024 | 81746 | 0.230 |
Why?
|
Diabetes Mellitus | 3 | 2020 | 5887 | 0.230 |
Why?
|
Orchiectomy | 2 | 2016 | 466 | 0.230 |
Why?
|
Evidence-Based Medicine | 2 | 2013 | 3701 | 0.220 |
Why?
|
Leuprolide | 2 | 2024 | 313 | 0.210 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2015 | 2043 | 0.210 |
Why?
|
Urinary Retention | 1 | 2023 | 101 | 0.210 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2024 | 11873 | 0.200 |
Why?
|
Follow-Up Studies | 14 | 2024 | 39345 | 0.200 |
Why?
|
Lymph Node Excision | 3 | 2023 | 1269 | 0.190 |
Why?
|
Aged, 80 and over | 22 | 2024 | 59598 | 0.190 |
Why?
|
Thiohydantoins | 1 | 2021 | 19 | 0.190 |
Why?
|
Early Detection of Cancer | 7 | 2024 | 3237 | 0.180 |
Why?
|
Kaplan-Meier Estimate | 7 | 2017 | 6517 | 0.180 |
Why?
|
Lower Gastrointestinal Tract | 1 | 2020 | 13 | 0.180 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2021 | 1536 | 0.170 |
Why?
|
Urology | 2 | 2017 | 384 | 0.170 |
Why?
|
Prednisone | 2 | 2024 | 1567 | 0.170 |
Why?
|
Ileus | 1 | 2020 | 65 | 0.170 |
Why?
|
Blood Transfusion | 4 | 2020 | 1308 | 0.170 |
Why?
|
Leiomyosarcoma | 2 | 2014 | 426 | 0.170 |
Why?
|
Length of Stay | 9 | 2020 | 6495 | 0.170 |
Why?
|
Vinblastine | 1 | 2021 | 487 | 0.170 |
Why?
|
Vasectomy | 1 | 2020 | 52 | 0.160 |
Why?
|
Cohort Studies | 10 | 2024 | 41749 | 0.160 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15660 | 0.160 |
Why?
|
Treatment Outcome | 22 | 2024 | 65364 | 0.160 |
Why?
|
Proportional Hazards Models | 10 | 2023 | 12536 | 0.160 |
Why?
|
Urea | 1 | 2021 | 448 | 0.150 |
Why?
|
Southeastern United States | 1 | 2018 | 93 | 0.150 |
Why?
|
Lymphatic Metastasis | 5 | 2018 | 2908 | 0.150 |
Why?
|
Acrylamide | 1 | 2018 | 59 | 0.150 |
Why?
|
Hormone Replacement Therapy | 1 | 2023 | 757 | 0.150 |
Why?
|
Urinary Tract Infections | 2 | 2023 | 804 | 0.150 |
Why?
|
Risk Assessment | 12 | 2024 | 24314 | 0.150 |
Why?
|
Risk Factors | 15 | 2023 | 74936 | 0.150 |
Why?
|
Databases, Factual | 9 | 2019 | 8082 | 0.140 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2024 | 1515 | 0.140 |
Why?
|
Hypogonadism | 1 | 2023 | 805 | 0.140 |
Why?
|
Muscles | 2 | 2021 | 1582 | 0.140 |
Why?
|
Medical Oncology | 2 | 2020 | 2341 | 0.140 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2021 | 542 | 0.140 |
Why?
|
Disease-Free Survival | 4 | 2018 | 6843 | 0.140 |
Why?
|
Odds Ratio | 4 | 2019 | 9666 | 0.140 |
Why?
|
Disease Progression | 8 | 2018 | 13665 | 0.140 |
Why?
|
Poultry | 1 | 2016 | 79 | 0.130 |
Why?
|
Combined Modality Therapy | 6 | 2021 | 8535 | 0.130 |
Why?
|
Deoxycytidine | 1 | 2021 | 887 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 5 | 2024 | 18062 | 0.130 |
Why?
|
Patient Readmission | 4 | 2018 | 3288 | 0.130 |
Why?
|
Female | 45 | 2024 | 397113 | 0.130 |
Why?
|
Robotics | 1 | 2023 | 813 | 0.130 |
Why?
|
Health Care Costs | 3 | 2018 | 3239 | 0.130 |
Why?
|
Lysine | 1 | 2021 | 1000 | 0.130 |
Why?
|
Conjunctivitis, Inclusion | 1 | 2015 | 3 | 0.130 |
Why?
|
Adult | 27 | 2024 | 223583 | 0.130 |
Why?
|
Testosterone | 2 | 2024 | 2491 | 0.130 |
Why?
|
Muscle, Smooth | 2 | 2017 | 931 | 0.130 |
Why?
|
Aspirin | 2 | 2018 | 3135 | 0.130 |
Why?
|
Mass Screening | 4 | 2024 | 5458 | 0.130 |
Why?
|
Nephrectomy | 2 | 2018 | 930 | 0.130 |
Why?
|
Case-Control Studies | 4 | 2018 | 22287 | 0.120 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 370 | 0.120 |
Why?
|
Spheniscidae | 1 | 2015 | 9 | 0.120 |
Why?
|
Polyubiquitin | 1 | 2015 | 68 | 0.120 |
Why?
|
Eggs | 1 | 2016 | 182 | 0.120 |
Why?
|
Antitoxins | 1 | 2015 | 75 | 0.120 |
Why?
|
Radio Frequency Identification Device | 1 | 2015 | 24 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2024 | 16041 | 0.120 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 251 | 0.120 |
Why?
|
Yersinia enterocolitica | 1 | 1994 | 13 | 0.120 |
Why?
|
Cisplatin | 1 | 2021 | 1658 | 0.120 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1027 | 0.120 |
Why?
|
Genome-Wide Association Study | 4 | 2019 | 12795 | 0.120 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14783 | 0.120 |
Why?
|
SEER Program | 5 | 2023 | 1444 | 0.120 |
Why?
|
Hospitals | 2 | 2018 | 3886 | 0.120 |
Why?
|
Acetaminophen | 1 | 2019 | 551 | 0.120 |
Why?
|
Accidents | 1 | 2015 | 164 | 0.120 |
Why?
|
Urogenital Neoplasms | 1 | 2015 | 130 | 0.120 |
Why?
|
Methotrexate | 1 | 2021 | 1721 | 0.120 |
Why?
|
Doxorubicin | 1 | 2021 | 2234 | 0.120 |
Why?
|
PTEN Phosphohydrolase | 1 | 2020 | 1120 | 0.110 |
Why?
|
R Factors | 1 | 2014 | 35 | 0.110 |
Why?
|
Histiocytoma | 1 | 2013 | 5 | 0.110 |
Why?
|
Rhabdomyolysis | 1 | 2015 | 150 | 0.110 |
Why?
|
Diet Surveys | 1 | 2018 | 1160 | 0.110 |
Why?
|
Chlamydia trachomatis | 1 | 2015 | 239 | 0.110 |
Why?
|
Spermatic Cord | 1 | 2013 | 23 | 0.110 |
Why?
|
Oncogene Proteins, Viral | 1 | 2015 | 342 | 0.110 |
Why?
|
Carcinoma, Papillary | 1 | 2018 | 792 | 0.110 |
Why?
|
Patient-Centered Care | 1 | 2023 | 1444 | 0.110 |
Why?
|
Fishes | 1 | 2016 | 606 | 0.110 |
Why?
|
Adenocarcinoma | 1 | 2010 | 6371 | 0.110 |
Why?
|
Urologic Surgical Procedures | 1 | 2015 | 281 | 0.100 |
Why?
|
Healthcare Disparities | 2 | 2019 | 3414 | 0.100 |
Why?
|
Anemia | 1 | 2022 | 1514 | 0.100 |
Why?
|
Hospital Costs | 4 | 2022 | 957 | 0.100 |
Why?
|
Escherichia coli | 2 | 2015 | 4215 | 0.100 |
Why?
|
Area Under Curve | 1 | 2016 | 1642 | 0.100 |
Why?
|
Denmark | 1 | 2014 | 776 | 0.100 |
Why?
|
Body Mass Index | 2 | 2022 | 13053 | 0.090 |
Why?
|
Piperidines | 1 | 2020 | 1667 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 4 | 2018 | 36742 | 0.090 |
Why?
|
Telomere | 1 | 2017 | 943 | 0.090 |
Why?
|
Prognosis | 9 | 2024 | 29979 | 0.090 |
Why?
|
Nomograms | 1 | 2013 | 236 | 0.090 |
Why?
|
Liposarcoma | 1 | 2013 | 289 | 0.090 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15442 | 0.090 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2013 | 271 | 0.090 |
Why?
|
Administration, Intravesical | 2 | 2022 | 88 | 0.090 |
Why?
|
MicroRNAs | 2 | 2019 | 3804 | 0.090 |
Why?
|
Rhabdomyosarcoma | 1 | 2013 | 358 | 0.090 |
Why?
|
Perioperative Care | 1 | 2018 | 1043 | 0.090 |
Why?
|
Minority Groups | 1 | 2018 | 1217 | 0.090 |
Why?
|
United States | 14 | 2024 | 73027 | 0.090 |
Why?
|
Biofeedback, Psychology | 1 | 2011 | 117 | 0.090 |
Why?
|
HEK293 Cells | 2 | 2019 | 4289 | 0.090 |
Why?
|
Urination Disorders | 1 | 2011 | 236 | 0.080 |
Why?
|
Registries | 2 | 2018 | 8377 | 0.080 |
Why?
|
Anti-Bacterial Agents | 3 | 2023 | 7470 | 0.080 |
Why?
|
Survival Rate | 6 | 2020 | 12828 | 0.080 |
Why?
|
Diet | 2 | 2018 | 8087 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1942 | 0.080 |
Why?
|
Genome, Bacterial | 1 | 2013 | 796 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3251 | 0.080 |
Why?
|
ROC Curve | 1 | 2016 | 3628 | 0.080 |
Why?
|
Pain, Postoperative | 1 | 2019 | 1765 | 0.080 |
Why?
|
Time Factors | 6 | 2020 | 40214 | 0.070 |
Why?
|
Movement | 1 | 2015 | 1490 | 0.070 |
Why?
|
Guideline Adherence | 2 | 2017 | 2235 | 0.070 |
Why?
|
Immunotherapy | 1 | 2023 | 4748 | 0.070 |
Why?
|
Survival Analysis | 5 | 2019 | 10098 | 0.070 |
Why?
|
Escherichia coli Proteins | 1 | 2014 | 1058 | 0.070 |
Why?
|
DNA Replication | 1 | 2014 | 1427 | 0.070 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5366 | 0.070 |
Why?
|
Drug Resistance, Bacterial | 1 | 2014 | 1063 | 0.070 |
Why?
|
Cell Division | 1 | 2014 | 4473 | 0.070 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13658 | 0.060 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4785 | 0.060 |
Why?
|
Propensity Score | 3 | 2019 | 1970 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6515 | 0.060 |
Why?
|
Internship and Residency | 2 | 2016 | 5952 | 0.060 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2013 | 944 | 0.060 |
Why?
|
Urinary Bladder | 2 | 2022 | 1157 | 0.060 |
Why?
|
Decision Making | 2 | 2024 | 3952 | 0.060 |
Why?
|
Age Factors | 2 | 2019 | 18407 | 0.060 |
Why?
|
Drug Prescriptions | 1 | 2014 | 1667 | 0.060 |
Why?
|
Testis | 1 | 2008 | 783 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2015 | 2982 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2018 | 14718 | 0.060 |
Why?
|
Suicide | 1 | 2015 | 1606 | 0.060 |
Why?
|
Body Weight | 1 | 2015 | 4628 | 0.060 |
Why?
|
Overweight | 1 | 2015 | 2448 | 0.060 |
Why?
|
Neoplasm Metastasis | 3 | 2021 | 4904 | 0.060 |
Why?
|
Surgical Procedures, Operative | 1 | 2015 | 1932 | 0.060 |
Why?
|
Cell Proliferation | 2 | 2019 | 10470 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2016 | 3619 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2015 | 3079 | 0.050 |
Why?
|
Apoptosis | 2 | 2019 | 9521 | 0.050 |
Why?
|
Logistic Models | 4 | 2020 | 13289 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2013 | 4248 | 0.050 |
Why?
|
Retroperitoneal Space | 1 | 2023 | 175 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2016 | 3800 | 0.050 |
Why?
|
Contrast Media | 2 | 2013 | 5330 | 0.050 |
Why?
|
Organ Size | 1 | 2008 | 2267 | 0.050 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 2420 | 0.050 |
Why?
|
Mycobacterium tuberculosis | 1 | 2013 | 1930 | 0.050 |
Why?
|
Multivariate Analysis | 4 | 2017 | 12075 | 0.050 |
Why?
|
Gallium Radioisotopes | 1 | 2023 | 195 | 0.050 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2018 | 1788 | 0.050 |
Why?
|
Mutation | 2 | 2018 | 30211 | 0.050 |
Why?
|
Drug Utilization Review | 1 | 2003 | 248 | 0.050 |
Why?
|
Uganda | 2 | 2016 | 1361 | 0.040 |
Why?
|
Obesity | 1 | 2022 | 13091 | 0.040 |
Why?
|
Insulin | 1 | 2014 | 6606 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2003 | 854 | 0.040 |
Why?
|
Blotting, Western | 2 | 2019 | 5024 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2024 | 998 | 0.040 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2023 | 452 | 0.040 |
Why?
|
Physicians | 1 | 2017 | 4598 | 0.040 |
Why?
|
Genomics | 3 | 2021 | 5925 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 565 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 644 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13499 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9614 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 4055 | 0.040 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2004 | 707 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 13000 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2019 | 794 | 0.040 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2024 | 1065 | 0.040 |
Why?
|
Doxycycline | 1 | 2019 | 348 | 0.040 |
Why?
|
Melanoma | 1 | 2015 | 5706 | 0.030 |
Why?
|
Positron-Emission Tomography | 3 | 2023 | 6668 | 0.030 |
Why?
|
Heart Valve Diseases | 1 | 2004 | 1030 | 0.030 |
Why?
|
Aorta | 1 | 2004 | 2045 | 0.030 |
Why?
|
Surgical Wound Dehiscence | 1 | 2017 | 216 | 0.030 |
Why?
|
Androgens | 1 | 2024 | 1281 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5861 | 0.030 |
Why?
|
Breeding | 1 | 2015 | 49 | 0.030 |
Why?
|
Computational Biology | 2 | 2019 | 3568 | 0.030 |
Why?
|
Gastrointestinal Agents | 1 | 2020 | 511 | 0.030 |
Why?
|
Yersinia Infections | 1 | 1994 | 9 | 0.030 |
Why?
|
Perioperative Period | 1 | 2016 | 252 | 0.030 |
Why?
|
Adolescent | 6 | 2017 | 89155 | 0.030 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2004 | 1456 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 14163 | 0.030 |
Why?
|
Canada | 2 | 2003 | 2129 | 0.030 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2004 | 1566 | 0.030 |
Why?
|
Child | 6 | 2016 | 80906 | 0.030 |
Why?
|
Cell Death | 1 | 2019 | 1679 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12252 | 0.030 |
Why?
|
Hospital Mortality | 2 | 2019 | 5349 | 0.030 |
Why?
|
Surgical Wound Infection | 1 | 2023 | 1546 | 0.030 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2019 | 1137 | 0.030 |
Why?
|
Cats | 1 | 1994 | 975 | 0.030 |
Why?
|
Urethra | 1 | 2015 | 406 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1157 | 0.030 |
Why?
|
Automation | 1 | 2015 | 589 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2017 | 1736 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2018 | 3435 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2017 | 714 | 0.020 |
Why?
|
Mendelian Randomization Analysis | 1 | 2017 | 1040 | 0.020 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2012 | 234 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2018 | 10396 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2019 | 2131 | 0.020 |
Why?
|
Stents | 1 | 2023 | 3195 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6314 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2014 | 563 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2013 | 412 | 0.020 |
Why?
|
Quality Improvement | 2 | 2016 | 3855 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8740 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2014 | 2559 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4114 | 0.020 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2016 | 1149 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3476 | 0.020 |
Why?
|
Comorbidity | 2 | 2017 | 10590 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2018 | 2048 | 0.020 |
Why?
|
Eating | 1 | 2016 | 1542 | 0.020 |
Why?
|
Recovery of Function | 1 | 2020 | 2981 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2016 | 2916 | 0.020 |
Why?
|
Dogs | 1 | 1994 | 3844 | 0.020 |
Why?
|
Leukocytes | 1 | 2017 | 2035 | 0.020 |
Why?
|
History, 21st Century | 1 | 2015 | 1572 | 0.020 |
Why?
|
Phenotype | 2 | 2017 | 16723 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1207 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1594 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2015 | 1793 | 0.020 |
Why?
|
Cattle | 1 | 1994 | 3819 | 0.020 |
Why?
|
Young Adult | 4 | 2017 | 60048 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2015 | 2357 | 0.020 |
Why?
|
Fibrosis | 1 | 2015 | 2080 | 0.020 |
Why?
|
Pain Measurement | 1 | 2019 | 3583 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4854 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 1994 | 1967 | 0.020 |
Why?
|
Child, Preschool | 3 | 2016 | 42665 | 0.020 |
Why?
|
Genetic Loci | 1 | 2017 | 2629 | 0.020 |
Why?
|
Heart Defects, Congenital | 1 | 2004 | 4713 | 0.020 |
Why?
|
Elasticity Imaging Techniques | 1 | 2012 | 398 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 2015 | 1061 | 0.020 |
Why?
|
History, 20th Century | 1 | 2015 | 2766 | 0.020 |
Why?
|
Primary Health Care | 1 | 2024 | 4746 | 0.020 |
Why?
|
Lung Diseases | 1 | 2017 | 1944 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 1753 | 0.020 |
Why?
|
Neutrophils | 1 | 2019 | 3786 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5536 | 0.020 |
Why?
|
Urinary Incontinence | 1 | 2011 | 490 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2024 | 4884 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4258 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3966 | 0.020 |
Why?
|
Smoking | 1 | 2023 | 9089 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 15597 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10627 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2016 | 2726 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2016 | 26420 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2019 | 12464 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4146 | 0.010 |
Why?
|
Health Personnel | 1 | 2018 | 3385 | 0.010 |
Why?
|
Obesity, Morbid | 1 | 2015 | 1298 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9609 | 0.010 |
Why?
|
Hemorrhage | 1 | 2016 | 3467 | 0.010 |
Why?
|
Critical Care | 1 | 2016 | 2715 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9368 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8748 | 0.010 |
Why?
|
Infant | 2 | 2016 | 36534 | 0.010 |
Why?
|
Base Sequence | 1 | 2014 | 12418 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20218 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9536 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3837 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3780 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8052 | 0.010 |
Why?
|
Ultrasonography | 1 | 2015 | 6004 | 0.010 |
Why?
|
Image Enhancement | 1 | 2012 | 2880 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17617 | 0.010 |
Why?
|
Biopsy | 1 | 2012 | 6786 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20757 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2003 | 1377 | 0.010 |
Why?
|
Hospital Information Systems | 1 | 2003 | 395 | 0.010 |
Why?
|
Drug Labeling | 1 | 2003 | 250 | 0.010 |
Why?
|
Models, Biological | 1 | 2015 | 9493 | 0.010 |
Why?
|
Animals | 3 | 2016 | 169222 | 0.010 |
Why?
|
Hospitalization | 1 | 2019 | 10840 | 0.010 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2003 | 463 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 13489 | 0.010 |
Why?
|
Aortic Valve | 1 | 2004 | 1970 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23642 | 0.010 |
Why?
|